Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > AGM Date: June 29, 2023

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Apr 25, 2023 3:52pm

138 Views

Post# 35413170

RE:RE:RE:RE:AGM Date: June 29, 2023

Thanks again Eoganacht April 29/2022 (last year) was on a Friday. In my positive opinion to be able to provide the latest patient update for AUA TLT will release those numbers somewhere between this Friday and the following Monday. Enjoy the fire sale, it won't last long. Both shares & warrants are going for a bargain.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant